Biotech: Page 46
-
Last Word
Pharma Forecast Simon King, a pharmaceutical company analyst at Datamonitor, comments on trends expected to impact “big pharma" in 2011. PV: Despite a challenging year for Roche, you say restructuring will help the company maintain a strong fiscal position. What other factors do you think will h...
By PharmaVoice Team • Dec. 27, 2010 -
Talent Pool
Pharmaceutical POOL Dr. Milind DESHPANDE Achillion Pharmaceuticals Promotes R&D President Achillion Pharmaceuticals, which is focused on the discovery and development of small-molecule drugs to combat challenging infectious diseases, has promoted Chief Scientific Officer Milind Deshpande, Ph....
By PharmaVoice Team • Dec. 27, 2010 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: New Solutions Help Harness Social Monitoring Insights CRM Update In Other Technology News… AstraZeneca BioClinica Chiltern International Cmed Technology Decision Resources PharmaVigilant E-Upgrades and Enhancement...
By PharmaVoice Team • Dec. 27, 2010 -
What's New
Trends: Changing market forces and the trend toward more flexible business models have inspired the creation of dynamic companies better positioned to explore opportunities overlooked by larger life-sciences organizations. NEW AMERICAN THERAPEUTICS, a specialty pharmaceutical company co-founded ...
By PharmaVoice Team • Dec. 27, 2010 -
UpFront
Awards… Abbott Diversity Leader John F. Crowley Honored Rx club Awards Dr. Paul Janssen Award Industry at Large Merck & The Street Executive Moves — Changes at the Top Podcasts White papers » Abbott Diversity Leader Abbott has been named one of the top 10 companies for diversity in a new surv...
By PharmaVoice Team • Dec. 27, 2010 -
A Globally Focused Industry
There will be an overall shift in the pharmaceutical industry from a very Western-centric model to a global one. Disease areas that were once considered niche are now given priority and the more prevalent disease therapeutic areas in the mature markets have taken a backseat. Vaccines, biologics, ...
By Denise Myshko • Nov. 10, 2010 -
A More Conservative Regulatory Landscape
In the last few years, the FDA has come under strong criticism for the rate of adverse events, high-profile drug recalls, and contamination of both food and drug products. Agency officials have made steps to address drug safety and provide a more open and transparent regulatory environment. For t...
By PharmaVoice Team • Nov. 10, 2010 -
The Crystal Ball
Dr. John Arrowsmith Scientific Director Thomson Reuters, which delivers critical information to leading decision makers in the financial, legal, tax and accounting, healthcare, science, and media markets. For more information, visit lifesciencesconsulting.thomsonreuters.com. 1. Outsourcing. There...
By PharmaVoice Team • Nov. 10, 2010 -
Talent Pool
Biopharmaceutical POOL Michael BAILEY Dr. Donna RADZIK Aveo Pharmaceuticals Bolsters Leadership Aveo Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics, has appointed Michael Bailey chief commercial officer. Mr. Bailey joins Av...
By PharmaVoice Team • Nov. 9, 2010 -
Women in Science: A Work in Progress
It’s a fact that gender discrepancy in the field of science exists. It’s a fact that changes in legislation, academic policies, and an overall increased awareness of gender bias are improving a woman’s chances of succeeding in all the STEM (science, technology, engineering, and math) fields. Howe...
By PharmaVoice Team • Sept. 29, 2010 -
Tomorrow's MSL: Specialist or Generalist?
MSLs have been around for 40 years, and with the evolution of technology, increased regulations and government scrutiny, and the squeeze of the declining salesforce, today the role may be even more crucial to the drug-development and commercialization process. According to Robin Winter-Sperry, M....
By PharmaVoice Team • Sept. 29, 2010 -
Pharma is Taking Its Byte of the Apple
Sales reps have been using mobile CRM applications on their smart phones and laptops for years, but the larger screen and “wow" factor of the iPad may bring additional benefits and functions to bear. Novelty of iPad Increases Mobile Technology Demand With the recent emergence of more s...
By PharmaVoice Team • Sept. 29, 2010 -
Last Word
Current Challenges in BioScience What are some of the hot button issues in biotechnology today? Molineaux. For small companies, it is all about funding and the difficulties associated with raising capital. There is a great deal of risk aversion in the capital community today, which is making thin...
By PharmaVoice Team • Sept. 28, 2010 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: CenterWatch Service Matches Sponsors, Investigative Sites PPD, Microsoft Collaborate to Improve REMS Management Cegedim Dendrite Streamlines Tracking, Reporting Capabilities QPharma Assists with Marketing Spend ...
By PharmaVoice Team • Sept. 28, 2010 -
UpFront
Awards Sanofi-Aventis Receives HBA’s ACE Award The Healthcare Businesswomen’s Association (HBA) has named Sanofi-Aventis US as the winner of the 2010 HBA ACE Award. The Sanofi-Aventis US program, WISE (Women Inspiring Sanofi-Aventis Excellence), is an internal women’s network with more than 1,000...
By PharmaVoice Team • Sept. 28, 2010 -
Letter from the Editor
The appeal of the iPad… It’s hard not to be seduced by the power of the 9.7-inch, high-resolution LED-backlit IPS display and incredible multi-touch capabilities, all bundled in a sleek casing that is light enough to take anywhere. The iPad, what will Steve Jobs and his techno-creatives think of ...
By Taren Grom • Sept. 28, 2010 -
Last Word
USING MONOCLONAL ANTIBODIES What are the opportunities for using monoclonal antibodies to treat Alzheimer’s disease? CHAIN: It took a long time to understand the hallmarks of Alzheimer’s disease. The beta amyloid plaques that appear in the brains of patients with Alzheimer’s are just a sign of wh...
By PharmaVoice Team • Aug. 26, 2010 -
The MENTORS
The MENTORS People’s People We salute those who take the time out of their own busy careers to help others to develop their paths to success; provide guidance; and exhibit patience, foresight, and unselfish devotion to mentoring. Knowledge is most valuable when shared, and Wendy Blackburn is one ...
By PharmaVoice Team • July 28, 2010 -
The TECHNOLOGISTS
Not many people have created two health-related companies, nor have had them both successfully acquired before their 30th birthday. But Hugo Stephenson, M.D., has an ability to see what others cannot and the energy to make things happens. As he says, he’s never yet met a challenge that could not ...
By PharmaVoice Team • July 28, 2010 -
Talent Pool
Pharma POOL Dr. Mike BURGESS, Roche Dr. Mikael DOLSTEN, Pfizer Kenneth FRAZIER, Merck Adam SCHECHTER, Merck Biotechnology POOL Robert BRADWAY, Amgen Dr. Henry LI, Kylin Therapeutics Kenneth MOCH, Chimerix Dr. George PAINTER, Chimerix Dr. Thomas PITLER, Chimerix Biopharmaceutical POOL Dr. John ALA...
By PharmaVoice Team • July 28, 2010 -
2010 DIA Preview
PharmaVOICE is pleased to once again publish this Special Feature showcasing the new products, services, tools, and executive appointments and promotions at clinical-services companies that will be exhibiting at the DIA 46th Annual Meeting, June 13-17, 2010, in Washington, D.C. For your convenie...
By PharmaVoice Team • May 24, 2010 -
Last Word
GLOBAL NEEDS What do you think is the biggest global health need? Joseph. As citizens of the developed world, we don’t often think about infectious and tropical diseases but malaria and tuberculosis, along with HIV, are alarmingly prevalent among the poorest people in the world. Every year, these...
By PharmaVoice Team • May 24, 2010 -
UpFront
Awards CURE Awards Bioscience Achievements Pfizer was awarded the CURE (Connecticut United for Research Excellence) Award for Excellence for its investment in multiple approaches to treating Alzheimer’s disease. Pfizer has seven Alzheimer’s clinical projects ongoing and several more programs i...
By PharmaVoice Team • May 24, 2010 -
The Healthcare Businesswomen's Association's Rising Stars
Amy Weickert. InfoMedics. Leaders need to have a clear vision and be able to articulate that vision and consistently drive others to believe that they can accomplish it. Leaders who I have admired are honest, communicate well, and create a positive environment of trust among their team members, a...
By PharmaVoice Team • April 28, 2010 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: BioClinica Launches System for Clinical-Trial Supply Planning New Quintiles Tool Accelerates Trial Recruitment Sidus Group Adds Life-Sciences Hosting Solution Paragon, NextDocs Collaborate on Clinical Optimizat...
By PharmaVoice Team • April 28, 2010